Purple Biotech (PPBT) Shareholder's Equity Growth (1y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Purple Biotech | 3.58 Bn | 3.57 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -70.65% |
| Sep 30, 2025 | 11.36% |
| Jun 30, 2025 | 9.10% |
| Mar 31, 2025 | 5.16% |
| Dec 31, 2024 | -4.04% |
| Sep 30, 2024 | -23.90% |
| Jun 30, 2024 | -31.27% |
| Mar 31, 2024 | -33.91% |
| Dec 31, 2023 | -27.18% |
| Sep 30, 2023 | -25.70% |
| Jun 30, 2023 | -23.20% |
| Mar 31, 2023 | -19.33% |
| Dec 31, 2022 | -27.66% |
| Sep 30, 2022 | -24.89% |
| Jun 30, 2022 | -22.83% |
| Mar 31, 2022 | -22.34% |
| Dec 31, 2021 | -18.36% |
| Jun 30, 2021 | 28.46% |
| Dec 31, 2020 | 634.43% |
| Jun 30, 2020 | 390.86% |
| Dec 31, 2019 | -1.32% |
| Jun 30, 2019 | 7.28% |
| Dec 31, 2018 | 26.66% |
| Jun 30, 2018 | -14.51% |
| Dec 31, 2017 | -35.09% |
| Jun 30, 2017 | 76.34% |
| Dec 31, 2016 | 41.96% |
| Dec 31, 2015 | 1,119.79% |
| Sep 30, 2015 | -91.04% |